Daewoong Pharmaceutical (India) Private Limited - Company Profile

It is a pharma foreign private limited company based in Hyderabad, Telangana, India, established in 2012.

2012 Hyderabad, Telangana, India Active

Last Updated: January 06, 2026

About Daewoong Pharmaceutical (India) Private Limited

Daewoong Pharmaceutical (India) Private Limited, a active foreign private limited company, was established on 30 November 2012 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232TG2012FTC084511. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹2.90 Cr and a paid-up capital of ₹2.86 Cr.

It upholds a compliant status. Employing 23 professional, Its leadership includes Neelima Aryasomayajula (Additional Director), Gwan Young Kim (Director), Chung Hyun Song (Director). Past directors included Insuk Oh, Minsuk Lee, Yong Hae Han. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No.5A, A.P.I.I.C Kukatpally, Hyderabad, Telangana, 500072.

Company Details

CIN/LLPIN
U24232TG2012FTC084511
Registration Number
084511
Incorporation Date
30 November 2012
Authorized Capital
₹2.90 Cr
Paid-Up Capital
₹2.86 Cr
ROC Code
Roc Hyderabad
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 2.90 Cr as on 06-01-2026
Paid Up Capital ₹ 2.86 Cr as on 06-01-2026
Company Age 13 Year, 3 Months
Last Filing with ROC 31 Mar 2025
Revenue Growth **** 2.90% (FY 2023)
Profit Growth **** -21.89% (FY 2023)
Ebitda **** 49.70% (FY 2023)
Net Worth 10.49% (FY 2023)
Total Assets **** 159.39% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Daewoong Pharmaceutical (India) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Daewoong Pharmaceutical (India) Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Neelima Aryasomayajula	Additional Director	21 May 2024	Current
Gwan Young Kim	Director	09 Apr 2018	Current
Chung Hyun Song	Director	08 Feb 2016	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	28 Jul 2017	Past
Pramod Abcsdd	Director	28 Jul 2017	Past
Pramod Abcsdd	Director	17 May 2018	Past
Pramod Abcsdd	Additional Director	21 Sep 2018	Past
Pramod Abcsdd	Director	07 Nov 2017	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Daewoong Pharmaceutical (India).

Daewoong Pharmaceutical (India) Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.9% increase. The company also saw a substantial fall in profitability, with a 21.89% decrease in profit. The company's net worth Soared by an impressive increase of 10.49%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

2.90%

*******

Revenue from Operations

*******

2.85%

*******

Total Assets

*******

159.39%

*******

Profit or Loss

*******

-21.89%

*******

Net Worth

*******

10.49%

*******

EBITDA

*******

49.70%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Daewoong Pharmaceutical (India)?

In 2023, Daewoong Pharmaceutical (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Daewoong Pharmaceutical (India)?

Daewoong Pharmaceutical (India) has a workforce of 23 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Daewoong Pharmaceutical (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Daewoong Pharmaceutical (India)'s trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Daewoong Pharmaceutical (India)

Recent Activity within the Organization

Annual General Meeting

Daewoong Pharmaceutical (India) Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
30 Sep 2025
Balance Sheet

Progress on Daewoong Pharmaceutical (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was documented.
31 Mar 2025
Director Appointment

Neelima Aryasomayajula was appointed as a Additional Director was appointed as a Additional Director on 21 May 2024 & has been associated with this company since 1 year 9 months . was recorded as a recent event.
21 May 2024
Director Appointment

The activity Gwan Young Kim was appointed as a Director was appointed as a Director on 09 Apr 2018 & has been associated with this company since 7 years 10 months . was completed.
09 Apr 2018
Director Appointment

Chung Hyun Song was appointed as a Director was appointed as a Director on 08 Feb 2016 & has been associated with this company since 10 years 25 days . was recorded as a recent event.
08 Feb 2016
Company Incorporation

Daewoong Pharmaceutical (India) Private Limited was registered on 30 Nov 2012 with Roc Hyderabad & aged 13 years 3 months as per MCA records. was recorded as a recent event.
30 Nov 2012

Explore recent activity and updates - View Recent Activity